Related Experiment Video
Updated: May 5, 2026
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Astrocytic Igfbp2 Promotes Spontaneous Seizures in a Mouse Model of Mesial Temporal Lobe Epilepsy
Shinichi Kinoshita1, Nobuyoshi Matsumoto1,2, Shota Morikawa1,3
1Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Abstract:
Mesial temporal lobe epilepsy (MTLE) is a common, frequently drug-resistant epilepsy characterized by seizures arising from the hippocampus. Its hallmark pathology is hippocampal sclerosis with neuronal loss and reactive astrogliosis. Although astrocytes have emerged as potential targets for antiepileptic therapies, their role in epilepsy development remains poorly defined. Here, we combined adeno-associated virus (AAV)-mediated labeling with translating ribosomal affinity purification (TRAP) to generate astrocyte-enriched transcriptome profiles from sclerotic hippocampal regions in a mouse model of MTLE. This analysis identified a marked upregulation of insulin-like growth factor-binding protein 2 (Igfbp2) in reactive astrocytes. Functional studies revealed that astrocytic Igfbp2 increases the excitability of dentate granule cells and promotes spontaneous recurrent seizures. These findings reveal Igfbp2 as a key astrocytic modulator of hippocampal excitability and identify it as a potential therapeutic target for epilepsy.
Insights
Researchers identified insulin-like growth factor-binding protein 2 (Igfbp2) in astrocytes as a key driver of seizures in mesial temporal lobe epilepsy (MTLE). Targeting astrocytic Igfbp2 may offer new epilepsy treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Mesial temporal lobe epilepsy (MTLE) is a common epilepsy type, often resistant to drugs.
- Hippocampal sclerosis, characterized by neuron loss and astrocyte activation, is the main pathology in MTLE.
- The precise role of astrocytes in epilepsy development is not fully understood.
Purpose of the Study:
- To investigate the role of astrocytes in MTLE pathogenesis.
- To identify molecular targets within astrocytes for potential epilepsy therapies.
Main Methods:
- Utilized a mouse model of MTLE.
- Employed adeno-associated virus (AAV)-mediated labeling and translating ribosomal affinity purification (TRAP) for astrocyte-specific transcriptome analysis.
- Conducted functional studies to assess the impact of identified genes on neuronal excitability and seizure activity.
Main Results:
- Identified significant upregulation of insulin-like growth factor-binding protein 2 (Igfbp2) in reactive astrocytes within the sclerotic hippocampus.
- Demonstrated that astrocytic Igfbp2 enhances dentate granule cell excitability.
- Showed that Igfbp2 promotes spontaneous recurrent seizures in the MTLE model.
Conclusions:
- Astrocytic Igfbp2 is a critical regulator of hippocampal excitability.
- Igfbp2 represents a potential therapeutic target for treating MTLE and other forms of epilepsy.
More Related Videos
09:29Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
09:49Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
